Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
242.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 12.00 (5.085%)
Market Cap: £26.56m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Directors Dealing

8 Oct 2014 07:00

RNS Number : 7044T
Alkane Energy PLC
08 October 2014
 

 

 

8 October 2014

 

Alkane Energy plc

("Alkane" or "the Company")

Directors Dealing - Exercise of Options

Alkane Energy PLC (AIM: ALK) announces that it has issued 1,107,000 new ordinary shares of 0.5p each ("Ordinary Shares") following the exercise of share options, by Directors, under the Company's Employee Performance Share Plan.

 

Neil O'Brien, Chief Executive Officer, exercised 620,625 options at an exercise price of 0.5p per share from a share option agreement dated 2011. On 7 October 2014, Neil O'Brien sold 297,785 shares at a price of 35.76p per share in order to satisfy exercise costs and cover the tax liability associated with the option exercise. As a result of this, Neil O'Brien's interest in the company increased to 1,071,840 representing 0.73% of the total voting rights of the Company.

 

Steve Goalby, Finance Director, exercised 486,375 options at an exercise price of 0.5p per share from a share option agreement dated 2011. On 7 October 2014, Steve Goalby sold 223,731 shares at a price of 35.76p per share in order to satisfy exercise costs and cover the tax liability associated with the exercise of options. As a result of this, Steve Goalby's interest in the company increased to 963,361 representing 0.65% of the total voting rights of the Company.

 

Application has been made to the London Stock Exchange for the 1,107,000 Ordinary Shares issued pursuant to the option exercise to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8:00 a.m. on 13 October 2014. The Ordinary Shares shall rank pari passu with the existing ordinary shares in the Company.

 

Following Admission, the Company's enlarged issued share capital and total number of voting rights will be 147,566,501 Ordinary Shares. There are no shares held in treasury.

 

Enquiries:

 

Alkane Energy plc

Neil O'Brien/Steve Goalby

 

Tel: +44 (0) 1623 827927

Liberum

Clayton Bush/Joshua Hughes

 

Tel: +44 (0) 20 3100 2000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFFRIDLDIIS
Date   Source Headline
13th Nov 20237:00 amRNSTVL First Feedstock Deal
1st Nov 202311:20 amRNSCorporate Presentation
31st Oct 202311:00 amRNSInvestor Webinar
27th Oct 20238:00 amRNSInterim Results for Period Ended 31 July 2023
24th Oct 20237:00 amRNSVSA lifts target price to £15.30 per share
3rd Oct 20237:00 amRNSUpdate on Lithium Feedstock and Offtake
29th Sep 20237:00 amRNSTVL Grant Funding Secured
23rd Aug 20238:00 amRNSFirst Lithium Sulphate Plant Study
1st Aug 202310:00 amRNSAustralia’s first Lithium Sulphate Plant
18th Jul 202311:00 amRNSResult of AGM
5th Jul 202311:00 amRNSAppointment of SI Capital as Corporate Broker
23rd Jun 202312:30 pmRNSNotice of Annual General Meeting
6th Jun 20234:00 pmRNSGrant of Options
31st May 20238:00 amRNS£1.35m Fundraise and Director Participation
31st May 20237:55 amRNSAnnual Report & Financial Statements
12th May 20238:00 amRNSMOU on process to unlock major Lithium feedstock
28th Apr 20238:00 amRNSTVL Management Recruitment
26th Apr 20238:00 amRNSMOU with Altilium Metals for lithium feedstock
20th Apr 20238:00 amRNSCorporate Update
17th Apr 20237:00 amRNSUK Minister Port Hedland Site Visit
31st Mar 20234:35 pmRNSPrice Monitoring Extension
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20237:00 amRNSCMA highlights TVL’s strategic importance
1st Mar 20237:00 amRNSTVL Accelerates Lithium Supply With BritishVolt
7th Feb 20237:00 amRNSMOU with Recharge Industries
24th Jan 20237:00 amRNSFirst phase approval from the UK ATF
19th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSSite secured for Port Hedland Lithium plant
20th Dec 20227:00 amRNSLong Term Lease Agreed for TVL’s Lithium Facility
5th Dec 20229:00 amRNSCorporate Presentation
25th Nov 20227:00 amRNSApproval for Europe's biggest Lithium Plant
8th Nov 20227:00 amRNSAppointment of Lead Engineering Partner
27th Oct 20227:00 amRNSInterim Results
12th Oct 20229:30 amRNSTVL and bp trial Green Hydrogen
29th Sep 20227:00 amRNSCorporate Update
23rd Aug 20228:45 amRNSInitiation of Research Report by Shard Capital
15th Aug 20227:00 amRNSAgreement with Weardale Lithium
12th Aug 20225:00 pmRNSHolding(s) in Company
8th Aug 20223:20 pmRNSCorrection: Placing and Directors Purchase
8th Aug 20227:00 amRNSAustralia’s First Lithium Sulphate Plant
4th Aug 20228:00 amRNSGrant of Options
4th Aug 20227:00 amRNSOversubscribed Placing and Director Purchase
21st Jul 20227:00 amRNSLithium Feedstock Agreement with Traxys
20th Jul 20223:15 pmRNSResult of AGM
20th Jun 20227:00 amRNSInitiation of Research Coverage by VSA Capital
17th Jun 202212:00 pmRNSNotice of Annual General Meeting
7th Jun 20227:00 amRNSBrokers Visit World Class Wilton International
23rd May 20227:00 amRNSManufacturer confirms TVL’s ultra pure Lithium
18th May 20227:00 amRNSAnnual Report & Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.